SEC 13F Intelligence

Managers / Q4 2024 · view latest →

BRIDGER MANAGEMENT, LLC

CIK 0001166309 · 90 PARK AVENUE, 40TH FLOOR, NEW YORK, NY, 10016 · 212-918-0820

Reported Value
$186M
Q4 2024
Positions
28
Filings on Record
37
2019–present window
Filed
Feb 14, 2025
original filing

Summary

Bridger Management, LLC reported $186M in U.S.-listed holdings across 28 positions for Q4 2024.

Its largest position, DWD, represents 12.7% of the portfolio.

Compared with Q3 2024, the fund opened 4 new positions and exited 5.

Portfolio Metrics

Turnover
+17.3%
vs prior filed quarter
Top-10 Concentration
+72.5%
share of reported value
Largest Position
+12.7%
Morgan Stanley
New / Exited
4 / 5
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.2BQ4 ’18Q1 ’19: $1.3BQ2 ’19: $1.3BQ3 ’19: $1.2BQ4 ’19: $1.4BQ4 ’19Q1 ’20: $864MQ2 ’20: $1.1BQ3 ’20: $1.3BQ4 ’20: $1.3BQ4 ’20Q1 ’21: $1.1BQ2 ’21: $1.1BQ3 ’21: $855MQ4 ’21: $773MQ4 ’21Q1 ’22: $610MQ2 ’22: $444MQ3 ’22: $330MQ4 ’22: $247MQ4 ’22Q1 ’23: $268MQ2 ’23: $300MQ3 ’23: $272MQ4 ’23: $260MQ4 ’23Q1 ’24: $222MQ2 ’24: $194MQ3 ’24: $200MQ4 ’24: $186MQ4 ’24Q1 ’25: $201MQ2 ’25: $170MQ3 ’25: $186MQ4 ’25: $156MQ4 ’25Q1 ’26: $128Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 83.9%ADR: 12.6%ETP: 3.5%Equity WRT: 0.0%
  • Common Stock · 83.9% · $156M
  • ADR · 12.6% · $23M
  • ETP · 3.5% · $7M
  • Equity WRT · 0.0% · $9,987

Quarter-over-Quarter Changes full breakdown →

vs Q3 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ZBHZIMMER BIOMET HOLDINGS INCNEW+90.5K90.5K+$10M$10M
GMABGENMAB A/SNEW+291.5K291.5K+$6M$6M
MAMASTERCARD INCORPORATEDNEW+2.4K2.4K+$1M$1M
HOODROBINHOOD MKTS INCNEW+26.7K26.7K+$994,842$994,842
OSCROSCAR HEALTH INCSOLD OUT413.8K0$9M$0
BMYBRISTOL-MYERS SQUIBB COSOLD OUT145.8K0$8M$0
CN2CATALYST PHARMACEUTICALS INCSOLD OUT90.7K0$2M$0
YB4PSAVARA INCSOLD OUT376.8K0$2M$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2024

28 positions
#IssuerClass% PortfolioValueShares
1DWDMORGAN STANLEYhistory →COM NEW12.68%$24M187.7K
2UBERUBER TECHNOLOGIES INChistory →COM9.38%$17M289.5K
3VRTXVERTEX PHARMACEUTICALS INChistory →COM8.88%$17M41.0K
4TEVATEVA PHARMACEUTICAL INDS LTDhistory →SPONSORED ADS8.23%$15M695.0K
5PFEPFIZER INChistory →COM6.64%$12M466.1K
6WYNNWYNN RESORTS LTDhistory →COM6.26%$12M135.2K
7ALNYALNYLAM PHARMACEUTICALS INChistory →COM5.21%$10M41.2K
8BBWIBATH & BODY WORKS INChistory →COM5.20%$10M249.6K
9ZBHZIMMER BIOMET HOLDINGS INChistory →COM5.14%$10M90.5K
10BLCOBAUSCH PLUS LOMB CORPhistory →COMMON SHARES4.91%$9M506.3K
11GMABGENMAB A/Shistory →SPONSORED ADS3.27%$6M291.5K
12XENEXENON PHARMACEUTICALS INChistory →COM3.09%$6M146.8K
13IBITISHARES BITCOIN TRUST ETFhistory →SHS BEN INT3.08%$6M108.2K
14SWTXUSDSPRINGWORKS THERAPEUTICS INChistory →COM2.81%$5M144.5K
15CZRCAESARS ENTERTAINMENT INC NEhistory →COM2.65%$5M147.6K
16GONGERON CORPhistory →COM2.55%$5M1.34M
17AMZNAMAZON COM INChistory →COM1.43%$3M12.1K
18GOOGLALPHABET INChistory →CAP STK CL A1.41%$3M13.9K
19MELCO RESORTS AND ENTMNT LTDADR1.10%$2M354.5K
20EWTXEDGEWISE THERAPEUTICS INChistory →COM1.07%$2M74.7K
21QTRXQUANTERIX CORPhistory →COM1.06%$2M185.1K
22TOSTTOAST INChistory →CL A1.03%$2M52.7K
23MSFTMICROSOFT CORPCOM0.96%$2M4.2K
24MAMASTERCARD INCORPORATEDCL A0.68%$1M2.4K
25HOODROBINHOOD MKTS INCCOM CL A0.53%$994,84226.7K
26VANECK ETF TRUSTGOLD MINERS ETF0.46%$853,82025.2K
27NEXTNEXTDECADE CORPCOM0.28%$523,02367.8K
28SRZNWSURROZEN INC*W EXP 08/01/2030.01%$9,987466.7K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$128M24May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$156M24Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$186M28Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$170M25Aug 11, 202513F-HRchanges · EDGAR ↗
Q1 2025$201M29May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$186M28Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$200M29Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$194M28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$222M31May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$260M28Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$272M31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$300M29Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$268M28May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$247M23Feb 15, 202313F-HRchanges · EDGAR ↗
Q3 2022$330M44Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$444M43Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$610M52May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$773M44Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$855M46Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.1B44Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.1B42May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.3B39Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.3B36Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.1B35Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$864M36May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.4B35Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.2B30Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.3B31Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.3B33May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.2B34Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.